25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province
- PMID: 24731736
- DOI: 10.1016/j.oraloncology.2014.03.009
25 year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province
Abstract
Objectives: Long term outcomes of patients with head and neck cancer (HNC) are rarely reported, but of potential benefit to clinicians and researchers. Squamous cell carcinomas (SCC) of the head and neck represent a heterogeneous group of cancers. The purpose of this population based study is to describe primary site specific, long term outcomes of HNC.
Methods: All patients from a Canadian province diagnosed between 1986 and 1990 with SCC of the oral cavity, pharynx, and larynx were identified. Chart review and patient data were abstracted through the provincial cancer registry database. Survival analysis was performed with Kaplan Meier methods, while differences in survival between groups were assessed with log-rank tests. Multivariable analysis was performed using Cox-regression.
Results: 1657 patients were analyzed during the study period. Almost half (50.9%) of the cases were advanced stage (stage III IV) at presentation. Two, 5, 15 & 25year overall survival (OS) and HNC specific survival for all the patients were 64%, 46%, 21%, 11% and 74%, 63%, 53% & 49%, respectively. OS and HNC-specific mortality were statistically inferior among men, older age at diagnosis, advanced stages of disease, and was primary cancer site specific, with worse survival in oropharyngeal & hypopharyngeal sites, p<0.001.
Conclusions: Survival rates vary by primary HNC site, and the overall survival & HNC specific survival differ over this long follow up assessment. Head and neck cancer specific death is most common in the first five years, and is subsequently dominated by competing causes of mortality. These results are useful as a reference tool for clinicians, researchers, and trainees.
Keywords: Head and neck cancer; Head and neck cancer specific survival; Overall survival; Population oncology; Retrospective study.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028. Laryngoscope. 2001. PMID: 11404625
-
Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.Laryngoscope. 2014 Oct;124(10):2287-91. doi: 10.1002/lary.24719. Epub 2014 May 30. Laryngoscope. 2014. PMID: 24729185
-
Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients.Head Neck. 2010 Jun;32(6):728-36. doi: 10.1002/hed.21245. Head Neck. 2010. PMID: 19827120
-
Alcohol-related head and neck cancer: Summary of the literature.Head Neck. 2020 Apr;42(4):732-738. doi: 10.1002/hed.26023. Epub 2019 Nov 27. Head Neck. 2020. PMID: 31777131 Review.
-
Impact of Time to Diagnosis and Treatment in Head and Neck Cancer: A Systematic Review.Otolaryngol Head Neck Surg. 2020 Apr;162(4):446-457. doi: 10.1177/0194599820906387. Epub 2020 Feb 25. Otolaryngol Head Neck Surg. 2020. PMID: 32093572
Cited by
-
Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium.J Oral Maxillofac Pathol. 2017 Jan-Apr;21(1):18-23. doi: 10.4103/0973-029X.203764. J Oral Maxillofac Pathol. 2017. PMID: 28479681 Free PMC article.
-
Primary Oral Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN): A Rare Case Report and Review of the Literature.Head Neck Pathol. 2024 Feb 23;18(1):13. doi: 10.1007/s12105-024-01613-w. Head Neck Pathol. 2024. PMID: 38393494 Free PMC article. Review.
-
Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect.Biomaterials. 2022 Oct;289:121769. doi: 10.1016/j.biomaterials.2022.121769. Epub 2022 Sep 1. Biomaterials. 2022. PMID: 36084485 Free PMC article.
-
Comparable Accuracy of Quantitative and Visual Analyses of [18F]FDG PET/CT for the Detection of Lymph Node Metastases from Head and Neck Squamous Cell Carcinoma.Diagnostics (Basel). 2023 Aug 10;13(16):2638. doi: 10.3390/diagnostics13162638. Diagnostics (Basel). 2023. PMID: 37627898 Free PMC article.
-
Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1.Oncotarget. 2019 Jan 11;10(4):494-510. doi: 10.18632/oncotarget.26563. eCollection 2019 Jan 11. Oncotarget. 2019. PMID: 30728900 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials